Levallorphan tartrate salt
SIGMA/L121 - ≥98% (HPLC), powder
Synonym: 17-
CAS Number: 71-82-9
Empirical Formula (Hill Notation): C19H25NO · C4H6O6
Molecular Weight: 433.49
EC Number: 200-767-3
MDL Number: MFCD00210203
Linear Formula: C19H25NO · C4H6O6
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C19H25NO.C4H6O6/c1-2-1 |
| InChI key | FWMLYVACGDQRFU-ZTMWJVNESA |
| optical activity | [α]22/D −35°, c = 0.38 in H2O(lit.) |
| originator | Roche |
| Quality Level | 100 ![]() |
| SMILES string | O[C@H]([C@@H](O)C(O)=O)C( |
| solubility | H2O: 5 mg/mL, clear |
| Biochem/physiol Actions: | Partial agonist (antagonist) at μ and δ opioid receptors. |
| Disclaimer: | Photosensitive |
| Features and Benefits: | This compound was developed by Roche . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P301 + P312 + P330 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352200 |


